Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84f6a2446fb229f27796a9e35da05f45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ca73a1cb47dbf46d4958e16fa30889 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N23-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T11-00 |
filingDate |
2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eb89fa8469a56b6aad1b3cba96ea321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8840e6c2a58235528fa9d7c9f4dab7f |
publicationDate |
2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03084567-A1 |
titleOfInvention |
Use of botulinum toxin for treating cardiovasular diseases |
abstract |
The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007143410-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007143411-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6974579-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006046065-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005204375-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007143411-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005067961-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2486937-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007143410-A2 |
priorityDate |
2002-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |